ELUTIA INC. - CLASS A
4.1600
25-November-24 16:45:01
15 minutes delayed
Stocks
+0.0400
+0.97%
Today's range
3.9915 - 4.2700
ISIN
N/A
Source
NASDAQ
-
Aziyo Biologics to Report First Quarter 2022 Financial Results on Monday, May 9, 2022
25 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Upcoming KOL Call Hosted by Cowen
12 Apr 2022 16:05:00 By Nasdaq GlobeNewswire
-
04 Apr 2022 08:00:02 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in the Lytham Partners Spring 2022 Investor Conference
31 Mar 2022 18:50:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Fourth Quarter and Full Year 2021 Financial Results
03 Mar 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in the Cowen 42nd Annual Health Care Conference
23 Feb 2022 16:01:00 By Nasdaq GlobeNewswire
-
17 Feb 2022 16:01:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Present at the H.C. Wainwright Bioconnect Virtual Conference
27 Dec 2021 16:01:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Closing of $14.0 Million Private Placement
08 Dec 2021 17:31:29 By Nasdaq GlobeNewswire
-
Aziyo Biologics Announces $14.0 Million Private Placement
06 Dec 2021 06:59:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences
15 Nov 2021 16:05:02 By Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Third Quarter 2021 Financial Results
09 Nov 2021 16:01:01 By Nasdaq GlobeNewswire
-
25 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in the 2021 Cantor Global Healthcare Conference
15 Sep 2021 16:05:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics Appoints Peter G. Edwards as General Counsel
31 Aug 2021 16:05:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics Reports Second Quarter 2021 Financial Results
09 Aug 2021 16:01:00 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Report Second Quarter 2021 Financial Results on Monday, August 9, 2021
26 Jul 2021 16:01:00 By Nasdaq GlobeNewswire
-
07 Jun 2021 08:00:02 By Nasdaq GlobeNewswire
-
Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study
28 Apr 2021 16:05:01 By Nasdaq GlobeNewswire
-
Aziyo Biologics to Participate in the Truist Securities Life Sciences Summit
26 Apr 2021 16:05:00 By Nasdaq GlobeNewswire